Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis

NCT07840924 is registered in ClinicalTrials.gov with Wageningen University as lead sponsor.

NCT NCT07840924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07840924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis
Lead sponsor
Wageningen University
Phase
Phase 2
Overall status
Completed
Start date
March 26, 2024
Completion date
March 28, 2026
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, multiple sclerosis, sleep quality